Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ADIPOQ anticorps

ADIPOQ Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN5690369
  • Antigène Voir toutes ADIPOQ Anticorps
    ADIPOQ (Adiponectin (ADIPOQ))
    Reactivité
    • 148
    • 60
    • 41
    • 17
    • 11
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 136
    • 65
    • 6
    • 3
    • 2
    • 1
    • 1
    Lapin
    Clonalité
    • 146
    • 66
    Polyclonal
    Conjugué
    • 123
    • 34
    • 16
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ADIPOQ est non-conjugé
    Application
    • 126
    • 100
    • 70
    • 33
    • 28
    • 24
    • 22
    • 18
    • 17
    • 12
    • 10
    • 8
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Specificité
    Recognizes human adiponectin. Detects a band of ~30  kDa by Western blot.
    Immunogène
    Recombinant human adiponectin.
    Top Product
    Discover our top product ADIPOQ Anticorps primaire
  • Indications d'application
    ELISA: (direct and indirect, 1:5,000-1:10,000). Western Blot: (1:5,000-1:10,000 using ECL, suggested blocking and dilution buffer is TBST with 0.05 % Tween 20 with 5 % skim milk, incubate 1 hour at room temperature). Optimal conditions must be determined individually for each application.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    Liquid. 0.2um-filtered solution in PBS,  pH 7.4. Contains no preservatives.
    Agent conservateur
    Without preservative
    Stock
    -20 °C
    Stockage commentaire
    Stable for at least 6 months after receipt when stored at -20°C.
  • Antigène
    ADIPOQ (Adiponectin (ADIPOQ))
    Autre désignation
    Adiponectin (ADIPOQ Produits)
    Synonymes
    anticorps ADP, anticorps DCAF9, anticorps 6720489L24Rik, anticorps 9330209L04Rik, anticorps Adp, anticorps Mamdc1, anticorps RNSVSP4U, anticorps SVSIV1, anticorps Svp4, anticorps ACDC, anticorps ACRP30, anticorps ADIPQTL1, anticorps ADPN, anticorps APM-1, anticorps APM1, anticorps GBP28, anticorps apM-1, anticorps 30kDa, anticorps APN, anticorps Acdc, anticorps Acrp30, anticorps Ad, anticorps adipo, anticorps apM1, anticorps ADN, anticorps acrpl, anticorps adipo-b, anticorps adipoql, anticorps zgc:153584, anticorps adipoq, anticorps WD and tetratricopeptide repeats 1, anticorps MAM domain containing glycosylphosphatidylinositol anchor 2, anticorps seminal vesicle secretory protein 4, anticorps adiponectin, C1Q and collagen domain containing, anticorps adiponectin, C1Q and collagen domain containing, b, anticorps adiponectin, C1Q and collagen domain containing L homeolog, anticorps WDTC1, anticorps Mdga2, anticorps Svs4, anticorps ADIPOQ, anticorps Adipoq, anticorps adipoqb, anticorps adipoq.L
    Sujet
    ACRP30 was identified as a novel adipocyte-specific synthesized and secreted protein with structural resemblance to complement factor C1q. Like adipsin, ACRP30 secretion is induced ~10-fold during adipocyte differentiation. Plasma levels are reduced in obese humans, and low levels are associated with insulin-resistance. Treatment of db/db mice with TZD increased ACRP30 levels.
    ID gène
    9370
    NCBI Accession
    NP_001171271
    UniProt
    Q15848
Vous êtes ici:
Support technique